Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bisoprolol fumarate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bisoprolol fumarate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bisoprolol fumarate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely bisoprolol 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bisoprolol fumarate 1.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bisoprolol fumarate 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bisoprolol fumarate 3.75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely bisoprolol fumarate 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bisoprolol fumarate + hydrochlorothiazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely bisoprolol 2.5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bisoprolol fumarate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 1.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 1.25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 3.75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 3.75 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bisoprolol fumarate 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bisoprolol fumarate 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 5 mg oral tablet |
Has precise active ingredient |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 10 mg oral tablet |
Has precise active ingredient |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 1.25 mg oral tablet |
Has precise active ingredient |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 2.5 mg oral tablet |
Has precise active ingredient |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 3.75 mg oral tablet |
Has precise active ingredient |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bisoprolol fumarate 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bisoprolol fumarate 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bisoprolol fumarate 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bisoprolol fumarate 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bisoprolol fumarate 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 2.5 mg and hydrochlorothiazide 6.25 mg oral tablet |
Has precise active ingredient |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bisoprolol fumarate 2.5 mg and hydrochlorothiazide 6.25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Bisoprolol fumarate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |